Please login to the form below

Not currently logged in
From: Regulatory

EC: medicines to remain part of health directorate

EU flagJuncker U-turns on decision to move drugs to enterprise and industry

From: Research

Roche outlines $3bn expansion for its Basel site

Roche Basel WettsteinbruekeDecade-long programme will see the Swiss pharma company boost its presence in its home city

From: Sales

Are you getting what you’re worth?

Sam Small salary surveyPMLiVE salary survey opens to gauge the state of play with industry pay

From: Sales

Bayer’s Xarelto wins another NICE recommendation

Bayer Xarelto rivaroxaban 2.5Deemed cost-effective use of NHS resources to prevent blood clots following a heart attack

Pharmacy with a future

The future of pharmacy in the UK

Community pharmacy dispensing is being challenged on three fronts

Freedom of Speech

Pharma lobbying in the US

Is it a matter of freedom of speech?

EMA expands adverse event reporting website

Opens it up to all nationally-authorised medicines

Cubist picks Robert Perez as its new CEO

He replaces Michael Bonney who will continue as chair

Cubist Robert Perez

Using video as part of a healthcare marketing strategy

Information and entertainment are not mutually exclusive in the moving image

Video To Make You Think

Emma Eatwell returns to Hanover

Will lead its Brussels healthcare business

Emma Eatwell, Hanover

US approval for Philips' telehealth applications

The programmes give clinicians real-time access to health data

Featured jobs

Subscribe to our email news alerts


Add my company
Watermeadow Medical US

Watermeadow Medical is an award-winning, international agency with offices in Oxford and Manchester, UK and New York, USA. ....

Latest intelligence

Online Physician Communities
Is the pharma industry bad?
Surveys of doctors and the public suggest not...
Salary survey now open - how will you measure up?
Take part for a chance to win a Kindle Fire HD tablet...
Online Physician Communities
M3 and partners win Digital Sales Aid Award
Wins for campaign to overcome limited doctor engagement with pharma-owned websites...